These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20458533)

  • 1. Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.
    Aich U; Meledeo MA; Sampathkumar SG; Fu J; Jones MB; Weier CA; Chung SY; Tang BC; Yang M; Hanes J; Yarema KJ
    Glycoconj J; 2010 May; 27(4):445-59. PubMed ID: 20458533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
    Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ
    J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiphilic block copolymer NPs obtained by coupling ricinoleic acid/sebacic acids and mPEG: Synthesis, characterization, and controlled release of paclitaxel.
    Zhou S; Sun W; Zhai Y
    J Biomater Sci Polym Ed; 2018 Dec; 29(18):2201-2217. PubMed ID: 30285542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
    Fiegel J; Fu J; Hanes J
    J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Internalization Mechanisms of Polyanhydride Particles: Implications for Rational Design of Drug Delivery Vehicles.
    Phanse Y; Lueth P; Ramer-Tait AE; Carrillo-Conde BR; Wannemuehler MJ; Narasihan B; Bellaire BH
    J Biomed Nanotechnol; 2016 Jul; 12(7):1544-52. PubMed ID: 29337493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile release of parathyroid hormone from an implantable delivery system.
    Liu X; Pettway GJ; McCauley LK; Ma PX
    Biomaterials; 2007 Oct; 28(28):4124-31. PubMed ID: 17576005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New polymeric carriers for controlled drug delivery following inhalation or injection.
    Fu J; Fiegel J; Krauland E; Hanes J
    Biomaterials; 2002 Nov; 23(22):4425-33. PubMed ID: 12219833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy.
    Li T; Wang Y; Chen J; Gao X; Pan S; Su Y; Zhou X
    Drug Deliv; 2020 Dec; 27(1):410-421. PubMed ID: 32133894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.
    Mishra S; Bedja D; Amuzie C; Foss CA; Pomper MG; Bhattacharya R; Yarema KJ; Chatterjee S
    Biomaterials; 2015 Sep; 64():125-135. PubMed ID: 26111596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and erosion properties of PEG-containing polyanhydrides.
    Hou S; McCauley LK; Ma PX
    Macromol Biosci; 2007 May; 7(5):620-8. PubMed ID: 17457940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo.
    Tang BC; Fu J; Watkins DN; Hanes J
    Biomaterials; 2010 Jan; 31(2):339-44. PubMed ID: 19796810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression.
    Aich U; Campbell CT; Elmouelhi N; Weier CA; Sampathkumar SG; Choi SS; Yarema KJ
    ACS Chem Biol; 2008 Apr; 3(4):230-40. PubMed ID: 18338853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled delivery systems for proteins using polyanhydride microspheres.
    Tabata Y; Gutta S; Langer R
    Pharm Res; 1993 Apr; 10(4):487-96. PubMed ID: 8483830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable Polyester of Poly (Ethylene glycol)-sebacic Acid as a Backbone for β -Cyclodextrin-polyrotaxane: A Promising Gene Silencing Vector.
    Ghodke S; Mahajan P; Gupta K; Ver Avadhani C; Dandekar P; Jain R
    Curr Gene Ther; 2019; 19(4):274-287. PubMed ID: 31393245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
    Almaraz RT; Aich U; Khanna HS; Tan E; Bhattacharya R; Shah S; Yarema KJ
    Biotechnol Bioeng; 2012 Apr; 109(4):992-1006. PubMed ID: 22068462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery.
    Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ
    J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable polyanhydride synthesized from sebacic acid and ricinoleic acid.
    Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
    J Control Release; 2017 Jul; 257():156-162. PubMed ID: 27126904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.